Published April 6, 2010
The European Directorate for the Quality of Medicines (EDQM) has granted Indena, Milan, Italy, a “Certificate of Suitability of the European Pharmacopoeia” (CEP) for two products: Myrtocyan bilberry fruit dry extract refined and standardized (Vaccinium myrtillus L. dry extract) and Valeroselect valerian dry hydroalcoholic extract. EDQM is the body responsible for granting CEPs to Active Pharmaceutical Ingredients which are covered by European Pharmacopoeia monographs. The purpose of the CEP certification procedure is to provide proof that the quality of the substances used in human and veterinary medicines are suitably controlled by the relevant monographs of the European Pharmacopoeia. These certificates are recognized by all European Union members and other countries, including Australia, Canada and Switzerland.